This invention describes the use of beta-3-adrenoceptor agonists for the treatment of functional bladder disorders, particularly stress incontinence andor mixed incontinence. The method comprises separating an injection molded tote into upper and lower portions by cutting the injection molded tote. The extendable tray structure is featured in extending and adjusting the length of the tray structure by positioning the locking elements in the stripe-shaped openings. An anchor has an optimal weight to surface area ratio. In one embodiment, the dryer system can be utilized in a non-solid-state polymer production process to dry the polymer particles prior to crystallization. As a device configuration, a recording layer of which, of Zn\u2014Ge\u2014Te, content of Zn, Cd or the like is 20 atom percent or more, content of at least one element selected from the group consisting of Ge and Sb is less than 40 atom percent, and content of Te is 40 atom percent or more is used.